Kathryn J. Ruddy, MD, MPH | Authors

Breast Cancer in Young Women: Clinical Decision-Making in the Face of Uncertainty

May 14, 2009

Breast cancer is the leading cause of cancer-related deaths in young women, and survival rates for young women with breast cancer are lower than for older women with breast cancer. This inferior survival is seen in spite of the fact that younger women often receive more aggressive therapy, as detailed in Dr. Peppercorn’s thoughtful review.[1]

Optimizing Endocrine Therapy in Premenopausal ER-Positive Breast Cancer Patients

January 01, 2009

The optimal endocrine therapy for premenopausal women with hormone receptor–positive early breast cancer remains elusive. Dr. Pritchard presents a thoughtful review of this important topic, including the historic context for the current controversy regarding the utility of ovarian suppression (either by medication or permanent ablation) in the adjuvant treatment of young women with breast cancer.